Registry of coronary artery ectasia cases in the Middle East
Official title: Middle East Coronary Artery Ectasia Registry (MECAER): Incidence, Management, and One-Year Prognosis: A Multi-Centre Prospective Cohort Study.
Run by Jordanian Research and Artificial Intelligence Group · NCT05213429 · Data updated 2026-11-12
This study is creating a detailed collection of information about patients with coronary artery ectasia in Jordan to better understand and manage this condition.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 11000 (estimated) |
| Sponsor | Jordanian Research and Artificial Intelligence Group Academic / other |
| Locations | 1 site (Amman) |
| Status | Recruiting |
| Started | September 1, 2024 |
| Main results expected | December 31, 2027 |
| Study ends | December 31, 2027 |
| Registry record updated | May 4, 2025 |
| Trial ID | NCT05213429 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults suspected of having coronary artery disease who are referred for elective coronary angiography and meet the criteria for coronary ectasia.
✕Probably not a fit
Patients under 18 years old or those who refuse to participate will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational project aims to create a detailed registry of coronary artery ectasia (CAE) cases in Jordan, the first of its kind in the region. It involves collaboration between healthcare providers in both public and private sectors who manage patients with CAE. The study will classify CAE based on angiographic severity and gather data on patient demographics, risk factors, and clinical presentations. The goal is to enhance understanding and management of CAE, which is often under-researched.
Why it matters
Potential benefit: If successful, this registry could improve diagnosis and treatment strategies for patients with coronary artery ectasia.
How similar studies have gone: While this approach is novel in the Middle East, similar registries in other regions have contributed to better understanding and management of coronary artery conditions.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Subjects with suspected CAD who are referred for elective coronary angiography and fit the Coronary ectasia definition. Exclusion Criteria: * Patient younger than 18 years old. * Patients who refuse to sign a consent form . Patients who are enrolled in another Ectasia study
Where it's running
-
Specialty Hospital
Amman, Jordan Recruiting
Study contacts
- Study coordinator: Mahmoud I Izraiq, MD, FACC, FSCAI
- Email: izraiq@yahoo.com
- Phone: 00962795652260
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Antithrombotic options for acute coronary syndrome with coronary artery ectasia
This trial tests whether using rivaroxaban instead of the usual aspirin plus clopidogrel better prevents clot-related complications in adults hospitalized with acute coronary syndrome who have coronary artery ectasia.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.